Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

100%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
3(75.0%)
Phase 4
1(25.0%)
4Total
Phase 3(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00005776Phase 3Terminated

Inhaled Nitric Oxide Study for Respiratory Failure in Newborns

Role: collaborator

NCT00009646Phase 3Completed

Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)

Role: collaborator

NCT00238927Phase 4Completed

Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma

Role: collaborator

NCT00007657Phase 3Completed

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

Role: collaborator

All 4 trials loaded